BACKGROUND
Few gene-disease associations identified by human genetic studies lead to new drugs that advance to first-in-human trials. Schizophrenia exemplifies this translational gap: thousands of gene-disease associations have been reported, but antipsychotics act via mechanisms introduced in the 1950s. To close the g...
N. Simons, Vibhuti Patel, Hao-Yuan Li et al.· Biological Psychiatry· 0 citations
NO-assisted LNPs are established as a unique platform for potent mRNA delivery, which provides a new paradigm for overcoming endosomal barriers and improving the efficacy of mRNA vaccines.
Zheng-Wei Liu, Dinglingge Cao, Xu-Cheng Hou et al.· Journal of Controlled Releas...· 0 citations
This work designed, synthesized, and tested a series of ionizable lipids and formulated them into CNS-accessing lipid nanoparticles (CA LNPs) to deliver mRNA, and the lead candidate, CA2d LNP, demonstrated efficient mRNA delivery across the blood-brain barrier following intravenous injection.
Si-Yu Wang, Yi-Chen Zhong, Chang Wang et al.· Proceedings of the National...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.